MedPath

Effects of a Physical Exercise Program on Microcirculation and Pregnancy Outcomes in Obese Pregnant Women

Not Applicable
Conditions
Pregnancy
Obesity
Interventions
Other: Physical exercise program
Registration Number
NCT02392741
Lead Sponsor
Karine Ferreira Agra
Brief Summary

This study aims to determine the effect of a physical exercise program on microcirculation and maternal and perinatal outcomes in obese women. A randomized clinical trial will be performed at IMIP with obese pregnant women assisted at the Instituto de Medicina Integral Professor Fernando Figueira (IMIP) prenatal service.

Detailed Description

Obesity in pregnancy is an important risk factor for adverse perinatal outcomes. Obesity leads to oxidative stress and vascular damage including microcirculation inflammation. Physical activity prevents cellular damage and provide a protective effect to the health of the mother and fetus. Although physical activity has been recommended for obese pregnant women, studies assessing the effects on the microcirculation of these women are scarce. This study aims to determine the effect of a physical exercise program on microcirculation and maternal and perinatal outcomes in obese women. A randomized clinical trial will be performed at IMIP with obese pregnant women assisted at the IMIP prenatal service. The intervention group will be submitted to an exercise program consisting of daily post prandial, 10' after breakfast, lunch and dinner. The control group will follow the routine prenatal IMIP. All pregnant women will be evaluated by a questionnaire to assess physical activity. Microcirculation function will be evaluated by a Laser-doppler flowmetry at baseline and eight weeks after intervention. All pregnant women will be followed until the delivery and immediate postpartum period to check their perinatal outcomes. All pregnant women will be advised to use a pedometer to record their daily steps. The study meets the recommendations of the National Health Council. This project was submitted and approved from the Ethics Committee for Research involving human subjets of IMIP. All participants will be duly informed about the aims of the study and will be included after signing the Informed Consent Form.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • Singleton pregnancy between 14 and 20 weeks gestation;
  • Literate women;
  • sedentary lifestyle.
Exclusion Criteria
  • Cognitive, auditory, visual or motor impairment, certified by a specialist;
  • Any pregnancy disorders or previous maternal diseases: diabetes type 1 or type 2, hypertensive disorders of pregnancy, hemodynamic instability, renal disease or collagen, vaginal bleeding;
  • Any medical or obstetric contraindication to perform physical activity.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Physical exercise programPhysical exercise programThe intervention group witch will be submitted to an exercise program consisting of daily post prandial, 10' after breakfast, lunch and dinner.
Primary Outcome Measures
NameTimeMethod
Effects on microcirculationchange from baseline microcirculation after 8 weeks

Microcirculation will be assessed using the Laser-doppler flowmetry manufacturers software (Moor Instruments, UK) and expressed in perfusion units (PU). The parameters that will be used to evaluate the microcirculation (microvascular function) are: resting skin blood flux (RF), maximum skin blood flux (MF) at peak PORH, the ratio of maximum level and flow at rest (MF/RF) and the area of hyperemia (AH) which is the graphical area under the curve formed during PORH.

Secondary Outcome Measures
NameTimeMethod
fetal or neonatal deathafter delivery

information obtained by death certificate. Nominal variable, dichotomous yes / no.

Gestational hypertensionat 30 weeks gestation

hypertension diagnosed after the twentieth week of gestation in previously normotensive women, which is not accompanied by proteinuria. Nominal and dichotomous variable of yes/no.

Gestational age at deliveryat delivery

gestational age at delivery measured in complete weeks - numeric variable and discrete

birth weightat birth

quantitative and continuous variable measures in grams.

head circumferenceat birth

head circumference of newborns measured in centimeters, according to the registration statement of anthropometric characteristics at birth.

necessity of hospitalization in the first week of lifeone week after delivery

information obtained through medical records. Nominal variable, dichotomous yes / no.

Gestational diabetesat 30 weeks gestation

glucose\> 92mg / dl before ingestion of 75g of glucose; glucose\> 180 mg / dl one hour after the ingestion of 75g of glucose; glucose\> 153 mg / dL during the second hour after ingestion of 75 g glucose.

Weight gainat admission on the study and till 40 weeks gestation

refers to the weight gain (kg) during pregnancy. Obtained from the difference between the weight in late pregnancy and the previous weight before pregnancy - numeric variable, continuous.

Apgar scoreat birth

scale ranging from one to ten according to health conditions at birth. Nominal variable, dichotomous type (one to ten).

Waist circumferenceat birth

waist circumference of the newborn measured in centimeters, according to the registration statement of anthropometric characteristics at birth. Numerical variable, continuous.

Occurrence of birth traumaat birth

information obtained through medical records. Nominal variable, dichotomous yes / no.

Preeclampsiaat 30 weeks gestation

Hypertension accompanied by proteinuria\> 300 mg in a sample of 24 hours (or 1+ in qualitative dipstick test). Nominal and dichotomous variable of yes / no.

Maternal deathwithin 42 days of termination of pregnancy

death of women during or within 42 days of termination of pregnancy, irrespective of the duration or location of the pregnancy, caused by any factor related to or aggravated by pregnancy or by measures taken in relation to it. Nominal variable, dichotomous yes / no.

birth heightat birth

quantitative and continuous variable measured in centimeters.

© Copyright 2025. All Rights Reserved by MedPath